🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
8.68
-0.36 (-3.98%)
At close: Nov 20, 2026, 4:00 PM EST
8.80
+0.12 (1.38%)
After-hours: Nov 20, 2026, 7:30 PM EST

Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $340.83 million. The enterprise value is $102.61 million.

Market Cap340.83M
Enterprise Value 102.61M

Important Dates

The last earnings date was Tuesday, November 3, 2026, after market close.

Earnings Date Nov 3, 2026
Ex-Dividend Date n/a

Share Statistics

CTNM has 39.27 million shares outstanding. The number of shares has increased by 36.25% in one year.

Current Share Class 35.35M
Shares Outstanding 39.27M
Shares Change (YoY) +36.25%
Shares Change (QoQ) +2.46%
Owned by Insiders (%) 1.11%
Owned by Institutions (%) 79.01%
Float 30.12M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.39
P/TBV Ratio 1.39
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 31.11, with a Debt / Equity ratio of 0.03.

Current Ratio 31.11
Quick Ratio 30.45
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -29.80% and return on invested capital (ROIC) is -20.68%.

Return on Equity (ROE) -29.80%
Return on Assets (ROA) -28.34%
Return on Invested Capital (ROIC) -20.68%
Return on Capital Employed (ROCE) -29.09%
Weighted Average Cost of Capital (WACC) 9.95%
Revenue Per Employee n/a
Profits Per Employee -$1.24M
Employee Count51
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -30.17% in the last 52 weeks. The beta is 1.07, so CTNM's price volatility has been similar to the market average.

Beta (5Y) 1.07
52-Week Price Change -30.17%
50-Day Moving Average 10.66
200-Day Moving Average 13.27
Relative Strength Index (RSI) 38.98
Average Volume (20 Days) 403,290

Short Selling Information

The latest short interest is 3.70 million, so 9.41% of the outstanding shares have been sold short.

Short Interest 3.70M
Short Previous Month 3.66M
Short % of Shares Out 9.41%
Short % of Float 12.27%
Short Ratio (days to cover) 2.82

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -72.41M
Pretax Income -63.46M
Net Income -63.46M
EBITDA -72.03M
EBIT -72.41M
Earnings Per Share (EPS) -$1.76
Full Income Statement

Balance Sheet

The company has $244.48 million in cash and $6.27 million in debt, with a net cash position of $238.22 million or $6.07 per share.

Cash & Cash Equivalents 244.48M
Total Debt 6.27M
Net Cash 238.22M
Net Cash Per Share $6.07
Equity (Book Value) 245.42M
Book Value Per Share 6.25
Working Capital 241.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.87 million and capital expenditures -$360,000, giving a free cash flow of -$52.23 million.

Operating Cash Flow -51.87M
Capital Expenditures -360,000
Depreciation & Amortization 383,000
Net Borrowing n/a
Free Cash Flow -52.23M
FCF Per Share -$1.33
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -36.25%
Shareholder Yield -36.25%
Earnings Yield -20.29%
FCF Yield -15.32%

Analyst Forecast

The average price target for CTNM is $21.43, which is 146.89% higher than the current price. The consensus rating is "Buy".

Price Target $21.43
Price Target Difference 146.89%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2